| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |